Loading institutional data...
Loading institutional data...
Held by 216 of 2,417 reporting institutions (95th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
The dividend exceeds free cash flow (238%) — funded from the balance sheet or debt, a red flag if it persists. Last year: $849.1M dividends + $97.1M buybacks = $946.2M returned on $357.0M FCF.
1 consecutive years of dividend increases · -6%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 0%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
A reverse discounted cash flow is not shown for a REIT.
Depreciation swamps reported earnings for a property owner — which is why FFO exists. EBITDA leverage and a net-income DCF both mislead here.
Classified from the filings: SIC code.
Leverage ratios is not shown for a REIT.
Depreciation swamps reported earnings for a property owner — which is why FFO exists. EBITDA leverage and a net-income DCF both mislead here.
Classified from the filings: SIC code.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $467.5M is below the $2.24B due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2026-03-31 (10-Q). The cash figure is from 2025-12-31, so the two are not the same balance-sheet date — the schedule has not been refiled since.
Thin coverage — earnings barely cover interest. Effective rate ~3.1% on $9.85B of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it. This year they exceeded net income, so the ribbons are capped at earnings and understate what was actually returned.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.82B 100.0% | $2.70B 100.0% | $2.18B 100.0% | $2.06B 100.0% | $1.90B 100.0% | $1.64B 100.0% | $1.24B 100.0% | $1.19B 100.0% | $1.85B 100.0% | $2.13B 100.0% |
| Cost of Revenue | — | $1.07B 39.8% | $902.1M 41.4% | $863.0M 41.9% | $773.3M 40.8% | $782.5M 47.6% | $405.2M 32.7% | $378.7M 31.8% | $666.3M 36.0% | $738.4M 34.7% |
| Selling, General & Admin | $90.4M 3.2% | $97.2M 3.6% | $95.1M 4.4% | $131.0M 6.4% | $98.3M 5.2% | $93.2M 5.7% | $93.0M 7.5% | $96.7M 8.1% | $88.8M 4.8% | $103.6M 4.9% |
| Total Operating Expenses | $2.61B 92.4% | $2.67B 98.7% | $902.1M 41.4% | $863.0M 41.9% | $773.3M 40.8% | $782.5M 47.6% | $405.2M 32.7% | $378.7M 31.8% | $666.3M 36.0% | $738.4M 34.7% |
| Interest Expense | $305.2M 10.8% | $280.4M 10.4% | $200.3M 9.2% | $172.9M 8.4% | $158.0M 8.3% | $218.3M 13.3% | $217.6M 17.5% | $261.3M 21.9% | $307.7M 16.6% | $464.4M 21.8% |
| Other Income (Expense), net | $70.0M 2.5% | $238.0M 8.8% | $93.3M 4.3% | $335.3M 16.3% | -$29.0M -1.5% | $282.1M 17.2% | $106.7M 8.6% | $800.6M 67.2% | $333.8M 18.1% | $122.3M 5.7% |
| Pretax Income | $284.3M 10.1% | $273.2M 10.1% | $314.9M 14.4% | $507.1M 24.6% | $128.4M 6.8% | $217.7M 13.2% | -$8.6M -0.7% | -$2.6M -0.2% | $10.9M 0.6% | $11.4M 0.5% |
| Income Tax Expense | $9.3M 0.3% | $4.3M 0.2% | -$9.6M -0.4% | -$4.4M -0.2% | -$3.3M -0.2% | -$9.4M -0.6% | -$5.5M -0.4% | -$4.4M -0.4% | -$1.3M -0.1% | $4.5M 0.2% |
| Net Income | $71.3M 2.5% | $243.1M 9.0% | $306.0M 14.0% | $500.4M 24.3% | $505.5M 26.7% | $413.6M 25.1% | $45.5M 3.7% | $1.06B 89.1% | $414.2M 22.4% | $627.7M 29.5% |
| Per Share | ||||||||||
| EPS (Basic) | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 | $0.77 | $0.09 | $2.25 | $0.88 | $1.34 |
| EPS (Diluted) | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 | $0.77 | $0.09 | $2.24 | $0.88 | $1.34 |
| Weighted Avg Shares (Basic) | 696.0M | 675.7M | 547.0M | 538.8M | 538.9M | 530.6M | 486.3M | 470.6M | 468.8M | 467.2M |
| Weighted Avg Shares (Diluted) | 696.0M | 676.2M | 547.3M | 539.1M | 539.2M | 531.1M | 489.3M | 475.4M | 468.9M | 467.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Ranked against 32 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IRM | $35.2B | 241.6× | 23.5× | 5.1× | 12.2% | — | 2.2% | -15.5% | 1.0% | 7.4× | 348 |
| EXR | $31.7B | 32.7× | 14.8× | 9.4× | 3.7% | 72.8% | 28.8% | 7.3% | 7.3% | -0.1× | 204 |
| AVB | $27.1B | 25.6× | 12.3× | 8.9× | 4.4% | — | 34.7% | 9.1% | 5.0% | 3.1× | 1 |
| VICI | $27.0B | 9.4× | — | 6.7× | 4.1% | 99.3% | 69.3% | 10.0% | 6.2% | — | 233 |
| SBAC | $19.6B | 18.9× | 21.9× | 7.0× | 5.1% | 75.5% | 37.4% | -21.7% | 13.1% | 8.6× | 151 |
| HST | $17.6B | 23.4× | — | 2.9× | 7.6% | — | 12.5% | 11.7% | 9.8% | — | 196 |
| ESS | $17.0B | 25.5× | 11.3× | 9.0× | 6.4% | 69.9% | 37.2% | 12.7% | 12.7% | -0.1× | 148 |
| KIM | $16.4B | — | 17.1× | 7.7× | 5.1% | — | 27.3% | 5.6% | 3.2% | 5.4× | 174 |
| LAMR | $16.1B | 27.6× | — | 7.1× | 2.7% | 67.0% | 25.9% | 57.3% | 13.2% | — | 205 |
| WY | $14.2B | 43.9× | 15.6× | 2.1× | -3.1% | 14.8% | 4.7% | 3.4% | 2.2% | 4.1× | 239 |
| OHI | $14.2B | 24.1× | 22.3× | 11.9× | 13.2% | — | 49.6% | 11.4% | 6.3% | 5.1× | 219 |
| REG | $13.7B | — | 12.1× | 8.8× | 6.9% | — | 34.0% | 7.6% | 4.5% | 3.1× | — |
| MAA | $13.7B | 31.3× | — | 6.2× | 0.8% | — | 20.2% | 7.9% | 7.9% | — | 172 |
| SUI | $13.7B | 10.3× | 112.4× | 5.9× | 2.0% | — | 61.3% | 20.3% | 20.3% | -4.9× | 114 |
| DOC | $13.1B | 189.4× | — | 4.6× | 4.5% | — | 2.5% | 1.0% | 0.4% | — | 216 |
| AHR | $11.5B | 126.0× | 19.0× | 5.1× | 9.1% | 20.6% | 3.1% | 2.1% | 2.1% | -0.2× | 131 |
| GLPI | $11.5B | 13.4× | 12.6× | 7.2× | 4.1% | — | 51.7% | 17.8% | 7.0% | 4.8× | 138 |
| ELS | $11.4B | 29.3× | — | 7.5× | 0.3% | — | 26.3% | 22.9% | 7.9% | — | 100 |
| UDR | $11.4B | 31.4× | 13.9× | 6.7× | 2.4% | — | 22.1% | 11.5% | 4.1% | 4.7× | 121 |
| EGP | $10.7B | 41.0× | — | 14.9× | 12.7% | — | 35.7% | 7.4% | 7.4% | — | 126 |
| BXP | $10.1B | 36.2× | — | 2.9× | 2.2% | 59.1% | 7.9% | 5.4% | 5.4% | — | 129 |
| FRT | $9.7B | 23.8× | — | 7.6× | 6.4% | — | 32.1% | 12.7% | 5.0% | — | 138 |
| RHP | $9.3B | 35.7× | 11.8× | 3.6× | 10.2% | 44.1% | 9.4% | 32.5% | 32.5% | -0.6× | 93 |
| CUBE | $9.3B | 28.1× | — | 8.3× | 5.3% | 68.7% | 29.5% | 12.2% | 12.2% | — | 107 |
| BRX | $8.9B | 23.3× | — | 6.5× | 6.7% | — | 28.2% | 12.8% | 4.5% | — | 94 |
Peers = companies sharing DOC's sector (Real Estate Investment Trusts) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-29 | 2 co-filers EVP and CAO | Grant | 1,358 | $15.46 | $21k |
| 2026-05-29 | 2 co-filers Chief Financial Officer | Grant | 937 | $15.46 | $14k |
| 2026-05-29 | 2 co-filers President and CEO | Grant | 1,347 | $15.46 | $21k |
| 2026-05-29 | 2 co-filers CIO | Grant | 625 | $15.46 | $10k |
| 2026-05-29 | 2 co-filers |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
EOD close · as of 2026-10-30
Cost of capital cannot be computed, so the spread is unknown.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 65.3% | -5.2% | 29.5% |
| FY2017 | 64.0% | -17.5% | 22.4% |
| FY2018 | 68.2% | 3.2% | 89.1% |
| FY2019 | 67.3% | -9.3% | 3.7% |
| FY2020 | 52.4% | -3.9% | 25.1% |
| FY2021 | 59.2% | 8.3% | 26.7% |
| FY2022 | 58.1% | 8.3% | 24.3% |
| FY2023 | 58.6% | 10.2% | 14.0% |
| FY2024 | 60.2% | 1.3% | 9.0% |
| FY2025 | not reported | 7.6% | 2.5% |
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: wacc.
| Grant |
| 1,385 |
| $15.46 |
| $21k |
| 2026-05-29 | 2 co-filers EVP and Treasurer | Grant | 1,358 | $15.46 | $21k |
| 2026-05-29 | 2 co-filers Chief Financial Officer | Tax withholding | 65 | $19.15 | $1k |
| 2026-05-29 | 2 co-filers EVP and Treasurer | Tax withholding | 94 | $19.15 | $2k |
| 2026-05-29 | 2 co-filers CIO | Tax withholding | 43 | $19.15 | $823 |
| 2026-05-29 | 2 co-filers EVP and CAO | Tax withholding | 76 | $19.15 | $1k |
| 2026-05-29 | 2 co-filers President and CEO | Tax withholding | 114 | $19.15 | $2k |
| 2026-05-29 | 2 co-filers Group filing | Tax withholding | 78 | $19.15 | $1k |
| 2026-05-14 | 2 co-filers President and CEO | Gift | 60,186 | $0.00 | — |
| 2026-05-14 | 2 co-filers President and CEO | Giftindirect | 60,186 | $0.00 | — |
| 2026-05-12 | Bohn Scott R CDO and Head of Lab | Open-market sale | 10,989 | $19.45 | $214k |
| 2026-05-06 | Lias-Booker Ava Director | Grant | 9,744 | $0.00 | $0 |
| 2026-05-06 | Sandstrom Katherine M Director | Grant | 9,744 | $0.00 | $0 |
| 2026-05-06 | Cartwright Brian G. Director | Grant | 9,744 | $0.00 | $0 |
| 2026-05-06 | Weiss Richard A. Director | Grant | 9,744 | $0.00 | $0 |
| 2026-05-06 | Connor James B. Director | Grant | 9,744 | $0.00 | $0 |
| 2026-05-06 | Griffin R Kent Jr Director | Grant | 9,744 | $0.00 | $0 |
| 2026-05-06 | Lewis Sara Grootwassink Director | Grant | 9,744 | $0.00 | $0 |
| 2026-02-16 | 2 co-filers EVP and Chief HR Officer | Tax withholding | 808 | $16.70 | $13k |
| 2026-02-15 | 2 co-filers EVP and Chief HR Officer | Tax withholding | 495 | $16.70 | $8k |
| 2026-02-07 | Alonso Lisa A EVP and Chief HR Officer | Tax withholding | 657 | $16.85 | $11k |
| 2026-02-07 | 2 co-filers Group filing | Tax withholding | 6,454 | $16.85 | $109k |
| 2026-02-06 | 2 co-filers Group filing | Grant | 23,739 | $0.00 | $0 |
| 2026-01-28 | 2 co-filers EVP and General Counsel | Grant | 11,256 | — | — |
| 2026-01-28 | 2 co-filers Chief Financial Officer | Grant | 33,462 | — | — |
| 2026-01-28 | 2 co-filers EVP and Treasurer | Grant | 1,079 | — | — |
| 2026-01-28 | 2 co-filers CIO | Grant | 2,156 | — | — |
| 2026-01-28 | 2 co-filers CDO and Head of Lab | Grant | 2,396 | — | — |
| 2026-01-28 | 3 co-filers EVP and Chief HR Officer | Grant | 456 | $0.00 | $0 |
| 2026-01-28 | 2 co-filers EVP and CAO | Grant | 1,198 | — | — |
| 2026-01-28 | 2 co-filers President and CEO | Grant | 14,133 | — | — |
| 2026-01-28 | 2 co-filers CIO | Grant | 31,575 | — | — |
| 2026-01-28 | 2 co-filers EVP and General Counsel | Grant | 36,765 | — | — |
| 2026-01-28 | 3 co-filers EVP and Chief HR Officer | Grant | 3,828 | $0.00 | $0 |
| 2026-01-28 | 2 co-filers Chief Financial Officer | Grant | 36,765 | — | — |
| 2026-01-28 | 2 co-filers President and CEO | Grant | 152,067 | — | — |
Where each multiple sits in its own 14-yr range · 71th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 1% against ROIC 0% — 1% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 112.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 31.8 | 32.7 | 47.6 | 40.8 | 41.9 | 41.4 | 39.8 | — |
| SG&A | 8.1 | 7.5 | 5.7 | 5.2 | 6.4 | 4.4 | 3.6 | 3.2 |
| Income Tax | -0.4 | -0.4 | -0.6 | -0.2 | -0.2 | -0.4 | 0.2 | 0.3 |
| Net Income | 89.1 | 3.7 | 25.1 | 26.7 | 24.3 | 14.0 | 9.0 | 2.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on DOC: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Return on equity (1%) and return on invested capital (0%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
Converts 1.38x of reported profit into free cash flow over 5 years, with accruals negative.
| Step | Amount | Running total |
|---|---|---|
| Net income | $71M | $71M |
| Share-based comp | $14M | $86M |
| Other non-cash & working capital | $1.17B | $1.25B |
| Operating cash flow | $1.25B | $1.25B |
| Capex | −$895M | $357M |
| Free cash flow | $357M | $357M |
| FCF after SBC | $343M | $343M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 32.6% | -5.7% | -38.4 points |
| FY2021 | 15.3% | 15.2% | -0.1 points |
| FY2022 | 8.7% | 9.8% | 1.1 points |
| FY2023 | 5.8% | 4.5% | -1.3 points |
| FY2024 | 23.8% | 37.6% | 13.8 points |
| FY2025 | 4.5% | 2.0% | -2.5 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 13.2 days | not reported | 412.1 days | -398.9 days |
| FY2020 | 9.4 days | not reported | 354.8 days | -345.4 days |
| FY2021 | 9.4 days | not reported | 356.6 days | -347.2 days |
| FY2022 | 9.5 days | not reported | 326.7 days | -317.3 days |
| FY2023 | 9.3 days | not reported | 265.9 days | -256.6 days |
| FY2024 | 10.4 days | not reported | 246.3 days | -235.9 days |
| FY2025 | 10.1 days | not reported | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -5.7 percent |
| FY2020 | -2.2 percent |
| FY2021 | -1.9 percent |
| FY2022 | -2.5 percent |
| FY2023 | -4.1 percent |
| FY2024 | -4.2 percent |
| FY2025 | -5.8 percent |
Shares outstanding are up 38% since FY2019 — per-share cash flow has grown more slowly than the totals above, and the gap is the owners'.
Leverage is not measurable this way for a reit.
Ladder as of 2026-03-31 (10-Q); cash from the 2025-12-31 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Depreciation swamps reported earnings for a property owner — which is why FFO exists. EBITDA leverage and a net-income DCF both mislead here.
Missing from our data, so excluded from this answer: capital adequacy metrics for this archetype.
At $18.94, free cash flow must compound 26.23%/yr for 10 years. It has done 13.3%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | −118.0% | 26.2% |
| FY2022 | −273.8% | 26.2% |
| FY2024 | 83.7% | 26.2% |
| FY2025 | 7.0% | 26.2% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The cost of capital could not be computed for this company, so the requirement is solved at the published 10% default — a different rate would move it materially.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.